Seeking Alpha

MD Research  

I have a diverse background—as a financial journalist, resident physician, mixed martial artist, painter, entrepreneur, chemistry instructor and web developer—that enabled me to pioneer the “Integrated Investing Research” approach.

I provide consulting to clients, both the retail and professional investors. I accurately forecasted many clinical trials, such as the Flint Trials for Intercept, the Ascend Trials for InterMune and the Affinity Trials MannKind, just to name a few. Through Vincata Enterprises, LLC, I helped many clients to unlock substantial values for their investments.

As an expert in biopharmaceutical analysis, I am also more than capable of analyzing any other industries. Though not ...More

See Seeking Alpha's policy on anonymous authors.

  • Description: CEO. Trading frequency: Infrequent
  • Interests: Bonds, Developed International Markets, Dividend stock ideas & income, Energy stocks, Options, REITs, Retirement savings, Stocks - long, Stocks - short, Tech stocks
Vincata Enterprises LLC Vincata is a Delaware private holding company with 100 percent ownership interest in Retail Investor 360.
Retail Investor 360 Retail Investor 360 is a unique news, education and analysis site that covers finance and medicine. With original research analysis, investment education and meaningful stocks news, Retail Investor 360 is the hidden gem, a niche destination, for both retail investors as well as market professionals.Our ...More
Currently, you have no book details. Click edit to add book details.
MannKind Corporation: Why The Mealtime Insulin Market Will Expand Drastically $MNKD, $SNY Aug 21, 2014